Skip to main content

Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension

Abstract

Introduction

P-wave dispersion (PWD) has been shown to be a non-invasive electrocardiographic predictor for development of atrial fibrillation (AF). Thus, it may be possible to decrease AF risk through improvement in PWD. Our objective was to compare the effects of cilazapril and atenolol on P-wave duration and dispersion in patients with hypertension.

Methods

A total of 38 newly diagnosed hypertensive patients were enrolled in the study. The patients were randomly assigned to receive treatment with either cilazapril (5 mg) or atenolol (50 mg). Doppler echocardiographic examination, P-wave durations and PWD were measured before and 1 mo after treatment

Results

Both drugs reduced blood pressure significantly (P<0.001). Posttreatment heart rate was significantly lower in the atenolol group (P=0.01). The change in maximum P-wave duration was not significant. However, both agents decreased PWD (P=0.001 and P<0.001) and increased the minimum P-wave duration (P=0.004 and P=0.02).

Conclusion

Both cilazapril and atenolol treatments resulted in improvement in PWD.

This is a preview of subscription content, access via your institution.

References

  1. Roithinger FX, Karch MR, Steiner PR, et al. The spatial dispersion of atrial refractoriness and atrial fibrillation vulnerability. J Interv Card Electrophysiol. 1999;3:311–319.

    PubMed  Article  CAS  Google Scholar 

  2. Michelucci A, Giuseppe B, Colella A, et al. P wave assessment: statement of the art update. Card Electrophys Rev. 2002;6:215–220.

    Article  Google Scholar 

  3. Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J. 2000;139:814–819.

    PubMed  Article  CAS  Google Scholar 

  4. Tukek T, Akkaya V, Atilgan D, et al. Effect of left atrial size and function on p-wave dispersion: a study in patients with paroxysmal atrial fibrillation. Clin Cardiol. 2001;24:676–680.

    PubMed  CAS  Article  Google Scholar 

  5. Øzer N, Aytemir K, Atalar E, et al. P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000;23:1127–1132.

    Article  Google Scholar 

  6. Himmelmann A, Kjeldsen SE, Hedner T. Recent hypertension guidelines. JNC-7 and 2003 ESH/ESC. Blood Press. 2003;12:196–197.

    PubMed  Article  Google Scholar 

  7. Pickering TG. Blood pressure measurement issues. In: Oparil S, Weber MA, eds. Hypertension: a Companion to Brenner and Rector’s The Kidney. Philadelphia: WB Saunders; 2000:306–313.

    Google Scholar 

  8. Henry WL, de Maria A, Gramiak R, et al. Report of the American Society of Echocardiography, Committee on Nomenclature and Standards. Circulation. 1980;62:212–222.

    PubMed  CAS  Google Scholar 

  9. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2006;48:e149–e246.

    Article  Google Scholar 

  10. Murray CJ, Lopez AD. Evidence based health policy-lessons from the Global Burden of Disease study. Science. 1996;274:740–743.

    PubMed  Article  CAS  Google Scholar 

  11. Dogan A, Ozaydin M, Nazli C, et al. Does impaired left ventricular relaxation affect P wave dispersion in patients with hypertension? Ann Noninvasive Electrocardiol. 2003;8:189–193.

    PubMed  Article  Google Scholar 

  12. Song J, Kalus JS, Caron MF, et al. Effect of diuresis on P wave duration and dispersion. Pharmacotherapy. 2002;22:564–568.

    PubMed  Article  Google Scholar 

  13. Faggiano P, D’Aloia A, Zanelli E, et al. Contribution of left atrial pressure and dimension to signal-averaged P-wave duration in patients with chronic congestive heart failure. Am J Cardiol. 1997;79:219–222.

    PubMed  Article  CAS  Google Scholar 

  14. Müller-Brunotte R, Edner M, Malmqvist K, Edner M. Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy. J Hum Hypertens. 2003;17:841–849.

    PubMed  Article  Google Scholar 

  15. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J. 2006;27:512–518.

    PubMed  Article  CAS  Google Scholar 

  16. L’Allier PL, Ducharme A, Keller PF, Yu H, Guertin MC, Tardif JC. Angiotensinconverting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol. 2004;44:159–164.

    PubMed  Article  CAS  Google Scholar 

  17. Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet. 1999;354:1751–1756.

    PubMed  Article  CAS  Google Scholar 

  18. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999;353:611–616.

    PubMed  Article  CAS  Google Scholar 

  19. Celik T, Iyisoy A, Kursaklioglu H, et al. The comparative effects of telmisartan and ramipril on P wave dispersion in hypertensive patients: a randomized clinical study. Clin Cardiol. 2005;28:298–302.

    PubMed  Article  Google Scholar 

  20. Webster MW, Fitzpatrick MA, Nicholls MG, Ikram H, Wells JE. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol. 1985;56:566–569.

    PubMed  Article  CAS  Google Scholar 

  21. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000;101:2612–2617.

    PubMed  CAS  Google Scholar 

  22. Kistler PM, Davidson NC, Sanders P, et al. Absence of acute effects of angiotensin II on atrial electrophysiology in humans. J Am Coll Cardiol. 2005;45:154–156.

    PubMed  Article  Google Scholar 

  23. Cheema A, Ahmed M, Kadish A, Goldberger J. Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol. 1995;26:497–502.

    PubMed  Article  CAS  Google Scholar 

  24. Erbay AR, Turhan H, Yasar AS, et al. Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis. Int J Cardiol. 2005;102:33–37.

    PubMed  Article  Google Scholar 

  25. Zhang J, Toher C, Erhard Y, et al. Relationships between myocardial bioenergetic and left ventricular function in hearts with volume overload hypertrophy. Circulation. 1997;96:334–343.

    PubMed  CAS  Google Scholar 

  26. Nemoto S, Hamawaki, M, De Freitas G, Carabello BA. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol. 2002;40:149–154.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mustafa Tuncer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tuncer, M., Gunes, Y., Guntekin, U. et al. Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension. Adv Therapy 25, 99–105 (2008). https://doi.org/10.1007/s12325-008-0012-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-008-0012-3

Keywords

  • atenolol
  • cilazapril
  • P-wave dispersion